Hi there,
Last week we introduced you to iboga - the ancient Bwiti plant medicine that stops opioid cravings in their tracks. This week, the President of the United States signed an Executive Order to fast-track it.
Trump's order directs the FDA to expedite psychedelic drugs that have received Breakthrough Therapy designation, opens a Right to Try pathway for veterans to access ibogaine and other investigational treatments, commits $50 million to match state psychedelic research programmes, and instructs the DEA to begin rescheduling reviews once Phase 3 trials are complete.
It is the most substantial federal action on psychedelics in US history. And it came from a Republican administration. (Reportedly it began with a text from Joe Rogan. Trump's reply: "Sounds great. Want FDA approval? Let's do it.") But no matter your politics, this is big news.
It's a strange and complicated moment. For those of us who have watched this field develop slowly and carefully for years, the speed is dizzying. And for those worried about what happens when plant medicines get caught up in pharmaceutical pipelines, political branding and stock market surges - those concerns are just as valid now as they ever were.
This is less a transformation of US psychedelic policy and more a targeted acceleration of existing pathways - the deeper questions of access, indigenous sovereignty, and what wise cultural integration actually looks like remain almost entirely untouched. The mainstream is arriving. Which makes the work of building the right culture around these medicines more urgent than ever.
That conversation is exactly what we exist for.
Check out our upcoming events this month and join us for Breaking Convention's One Day Summit, Saturday 16th May at Woolwich Works in London where researchers, clinicians, philosophers and artists are coming together for a day of serious, multidisciplinary during one of the most significant moments this field has ever seen.
We have a 10% discount for our community: use code PSYCHSOC10 at checkout. Get your ticket here.
MORE UPCOMING EVENTS
As always, you can find all our upcoming events and retreats on our events page.
hot topics in psychedelics
 |
 |
processing your experiences
 |
 |
 |
 |
connecting with the land
 |
 |
spaces for sharing
 |
 |
psychedelic retreats
 |
 |
community + connection
 |
 |
FROM OUR PARTNERS
Join us for a one day psychedelic conference in London featuring world-leading experts and speakers on Saturday 16th May 2026 in London and online. Whether you're curious about the headlines, interested in the science, or simply want to understand what all the fuss is about - this is a day designed for you.
Talks include
- Debate: Should Scientists be activists?
- Psychedelics in Times of War
- The Psychedelic Self: Science & Philosophy
- Psychedelics and Creativity
- Women and Psychedelics
- Living and Dying
+ more to be announced
We have a 10% discount for our community: use code PSYCHSOC10 at checkout.
The premier psychedelic research conference in Europe
Want to get in on the hottest conversations in psychedelics? ICPR is where science, practice, and policy meet. This is where you'll find intellectual rigour, cutting-edge evidence, and meaningful discussions on the real-world applications of psychedelics. With a strong focus on quality and integrity, ICPR is not about hype; it's about knowledge, impact, and the future of the field.
Join our community of members!
We fund our work in community-building and psychedelic education primarily through our membership program.
By becoming a member of The Psychedelic Society community, you get access to exclusive members-only events, a discount on events, and support the development of this alternative cultural space. Membership starts from just £5/month!
🌍Where in the world are you?🌍
We're updating our mailing lists to share events that are relevant to you in your area. Create (or update) your Dandelion profile with your country or postcode to start receiving them!